Dongdeuk Kwon

Dongdeuk Kwon

Auto-generated profile, based on publicly available information

Dongdeuk Kwon

Department of Urology, Chonnam National University Medical School, Gwangju, Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2022 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
JGJin Seok Gu
Jin Seok Gu
JRJi Won Ryu
Ji Won Ryu
SYSeong Hyeon Yu
Seong Hyeon Yu
HCHo Seok Chung
Ho Seok Chung
EHEu Chang Hwang
Eu Chang Hwang
DKDong Deuk Kwon
Dong Deuk Kwon
Gu JS, et al. Investig Clin Urol. 2022 Sep;63:e74. https://doi.org/10.4111/icu.20220204

1 January 2024 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
SJSeonguk Jeh
Seonguk Jeh
MCMinsung Choi
Minsung Choi
CKChangseok Kang
Changseok Kang
DKDaehyun Kim
Daehyun Kim
JCJaehwi Choi
Jaehwi Choi
JHJaeseog Hyun
Jaeseog Hyun
Jeh S, et al. Investig Clin Urol. 2024 Jan;65(1):69-76. https://doi.org/10.4111/icu.20230249

1 January 2023 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
SJSeung-Hwan Jeong
Seung-Hwan Jeong
SYSang Eun Yeon
Sang Eun Yeon
SKSu Youn Kim
Su Youn Kim
TKTae Gyun Kwon
Tae Gyun Kwon
SJSeong Soo Jeon
Seong Soo Jeon
CKCheol Kwak
Cheol Kwak
Jeong SH, et al. Investig Clin Urol. 2023 Aug;64:e54. https://doi.org/10.4111/icu.20230128

31 March 2024 in Journal of Urologic Oncology
Verified
Journal Article
Open access
PDF file
HGHui Mo Gu
Hui Mo Gu
SJSeung Il Jung
Seung Il Jung
DKDongdeuk Kwon
Dongdeuk Kwon
MKMyung Ha Kim
Myung Ha Kim
JJJae Hung Jung
Jae Hung Jung
EHEu Chang Hwang
Eu Chang Hwang
Purpose: The aim of this study was to assess the effects of tyrosine kinase inhibitors (TKIs) following metastasectomy in patients with metastatic renal cell carcinoma (mRCC).Materials and Methods: A systematic search of multiple electronic databases was conducted. The inclusion criteria encompassed randomized clinical trials evaluating the use of TKIs after metastasectomy in mRCC patients. Study outcomes were relapse-free survival (RFS)/disease-free survival (DFS), overall survival (OS), and adverse events of TKIs.Results: Two studies with 197 randomized participants that compared TKIs following metastasectomy versus metastasectomy alone were identified. According to these studies, TKIs following metastasectomy may result in little to no difference in RFS/DFS (hazard ratio [HR], 1.01; 95% confidence interval [CI], 0.65–1.57; I2=29%; low-certainty evidence). TKIs after metastasectomy may slightly increase OS, but the CI crossed the line of no effect (HR, 0.80; 95% CI, 0.06–9.87; I2=86%; low-certainty evidence). TKIs after metastasectomy likely resulted in a large increase in adverse events (risk ratio, 2.76; 95% CI: 1.65–4.62; I2=not applicable; moderatecertainty evidence).Conclusions: TKIs following metastasectomy did not improve RFS/DFS, but slightly improved OS. It is likely that TKIs following metastasectomy increase adverse events compared to surgery only. The certainty of evidence ranged from moderate (signaling confidence that the reported effect size is likely close to the true effect) to low (indicating that the true effect may be substantially different from the effect estimate). The findings of this study should help to inform future guidelines and clinical decision-making at the point of care.

1 July 2026 in Theater in Endourology and Robotics
Verified
Journal Article
Open access
PDF file
HLHo Yeon Lee
Ho Yeon Lee
HGHui Mo Gu
Hui Mo Gu
DLDo Gyeong Lim
Do Gyeong Lim
SYSeong Hyeon Yu
Seong Hyeon Yu
HCHo Seok Chung
Ho Seok Chung
EHEu Chang Hwang
Eu Chang Hwang
Ho Yeon Lee, Hui Mo Gu, Do Gyeong Lim, Seong Hyeon Yu, Ho Seok Chung, Kyung Jin Oh, Sun-Ouck Kim, Seung Il Jung, Taek Won Kang, Dongdeuk Kwon, Eu Chang Hwang. Theater Endourol. Robot. 2026;2:31-4. https://doi.org/10.64364/tier.26.0002

1 December 2025 in Theater in Endourology and Robotics
Verified
Journal Article
Open access
PDF file
HGHui Mo Gu
Hui Mo Gu
DLDo Gyeong Lim
Do Gyeong Lim
SYSeong Hyeon Yu
Seong Hyeon Yu
EHEu Chang Hwang
Eu Chang Hwang
KOKYUNG-JIN OH
KYUNG-JIN OH
HCHo Seok Chung
Ho Seok Chung
Hui Mo Gu, Do Gyeong Lim, Seung Hyeon Yu, Eu Chang Hwang, Kyung Jin Oh, Sun-Ouck Kim, Seung Il Jung, Taek Won Kang, Dongdeuk Kwon, Ho Seok Chung. Theater Endourol. Robot. 2025;1:21-3. https://doi.org/10.64364/tier.25.0002